Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1256]

ATTRACTION-5: Nivolumab plus chemotherapy as postoperative adjuvant treatment...

Dr Masanori Terashima - Shizuoka Cancer Center, Nagaizumi, Japan

ATTRACTION-5: Nivolumab plus chemotherapy as postoperative adjuvant treatment for pStage III G/GEJ cancer ( Dr Masanori Terashima - Shizuoka Cancer Center, Nagaizumi, Japan )

Optimising cervical cancer care in Nigeria

Prof Don Dizon - Rhode Island Hospital, Rhode Island, USA

Optimising cervical cancer care in Nigeria ( Prof Don Dizon - Rhode Island Hospital, Rhode Island, USA )

Tackling low-volumes of clinical trials in Africa

Prof Ifeoma Okoye - University of Nigeria, Nsukka, Nigeria

Tackling low-volumes of clinical trials in Africa ( Prof Ifeoma Okoye - University of Nigeria, Nsukka, Nigeria )

Choosing cancer medicines wisely in Africa

Dr Harrison Chuwa - Aga Khan Hospital, Dar es Salaam, Tanzania

Choosing cancer medicines wisely in Africa ( Dr Harrison Chuwa - Aga Khan Hospital, Dar es Salaam, Tanzania )

The HypoAfrica study and AC3T research partnerships at NLCC

Dr Adedayo Joseph - NSIA-LUTH Cancer Center, Lagos, Nigeria

The HypoAfrica study and AC3T research partnerships at NLCC ( Dr Adedayo Joseph - NSIA-LUTH Cancer Center, Lagos, Nigeria )

Achieving health equity in cancer care in the Philippines

Dr Rey Arturo Fernandez - Graduate School of Business, Makati City, The...

Achieving health equity in cancer care in the Philippines ( Dr Rey Arturo Fernandez - Graduate School of Business, Makati City, The Philippines )

Olaparib plus ceralasertib might benefit paediatric cancer patients with DNA...

Dr Susanne Gatz - Associate Clinical Professor in Paediatric Oncology, Cancer...

Olaparib plus ceralasertib might benefit paediatric cancer patients with DNA repair-deficient tumours ( Dr Susanne Gatz - Associate Clinical Professor in Paediatric Oncology, Cancer Research UK Clinical Trials Unit, University of Birmingham, Birmingham, UK )

Targeting BRAF V600E in metastatic colorectal cancer: where are we today?

Dr Rodrigo Motta Guerrero - ALIADA Contra el Cáncer, San Isidro, Peru

Targeting BRAF V600E in metastatic colorectal cancer: where are we today? ( Dr Rodrigo Motta Guerrero - ALIADA Contra el Cáncer, San Isidro, Peru )

War in Ukraine: Support from Lymphoma Coalition for Ukrainian haematological...

Prof Natacha Bolaños - Lymphoma Coalition, Madrid, Spain

War in Ukraine: Support from Lymphoma Coalition for Ukrainian haematological cancer patients ( Prof Natacha Bolaños - Lymphoma Coalition, Madrid, Spain )

Applying the syndemic framework to cancer research for effective cancer control...

Dr Zahid Butt - University of Waterloo, Waterloo, Canada

Applying the syndemic framework to cancer research for effective cancer control in LMICs ( Dr Zahid Butt - University of Waterloo, Waterloo, Canada )

Li-Fraumeni syndrome-associated dimer-forming mutant p53 promotes...

Dr Joshua Choe - Columbia University, New York City, USA

Li-Fraumeni syndrome-associated dimer-forming mutant p53 promotes transactivation-independent mitochondrial cell death ( Dr Joshua Choe - Columbia University, New York City, USA )

Pegargiminase-pemetrexed-platinum triplet therapy prolongs survival in non...

Prof Peter Szlosarek - Barts Cancer Institute, London, UK

Pegargiminase-pemetrexed-platinum triplet therapy prolongs survival in non-epithelioid pleural mesothelioma ( Prof Peter Szlosarek - Barts Cancer Institute, London, UK )

More from ecancer